Literature DB >> 15020234

Genetic variant Arg57His in human H+/peptide cotransporter 2 causes a complete loss of transport function.

Tomohiro Terada1, Megumi Irie, Masahiro Okuda, Ken-ichi Inui.   

Abstract

We evaluated the functional consequences of genetic variations in human H(+)/peptide cotransporter 2 (hPEPT2, SLC15A2) resulting in the amino acid changes Arg57His (R57H) and Pro409Ser (P409S). The transport activity of variant R57H was completely abolished, whereas that of variant P409S was comparable with that of wild-type hPEPT2 at pH 5.0-8.0. R57H variant protein was detected in the crude membranes of transiently expressed HEK293 cells by Western blot analysis. The expression of the R57H variant at the plasma membrane was confirmed by indirect immunofluorescence in Xenopus oocytes, suggesting that the loss of transport function of hPEPT2 R57H was not due to a change in membrane protein expression. This is the first demonstration of a functional impairment of the SLC15A family induced by a single nucleotide polymorphism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020234     DOI: 10.1016/j.bbrc.2004.02.063

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Distribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null mice.

Authors:  David E Smith; Yongjun Hu; Hong Shen; Tavarekere N Nagaraja; Joseph D Fenstermacher; Richard F Keep
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-23       Impact factor: 6.200

2.  Population pharmacokinetic modeling of cefadroxil renal transport in wild-type and Pept2 knockout mice.

Authors:  Yehua Xie; Hong Shen; Yongjun Hu; Meihua Rose Feng; David E Smith
Journal:  Xenobiotica       Date:  2015-09-15       Impact factor: 1.908

3.  Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1.

Authors:  Tomohiro Terada; Satohiro Masuda; Jun-Ichi Asaka; Masahiro Tsuda; Toshiya Katsura; Ken-ichi Inui
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

4.  Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants.

Authors:  Feifeng Song; Yongjun Hu; Huidi Jiang; David E Smith
Journal:  Drug Metab Dispos       Date:  2016-11-11       Impact factor: 3.922

Review 5.  Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity.

Authors:  Mohamed A Kamal; Richard F Keep; David E Smith
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

6.  Importance of Peptide transporter 2 on the cerebrospinal fluid efflux kinetics of glycylsarcosine characterized by nonlinear mixed effects modeling.

Authors:  Yeamin Huh; Scott M Hynes; David E Smith; Meihua R Feng
Journal:  Pharm Res       Date:  2013-02-01       Impact factor: 4.200

Review 7.  Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.

Authors:  David E Smith; Benjamin Clémençon; Matthias A Hediger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 8.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

9.  Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2.

Authors:  Simon Newstead; David Drew; Alexander D Cameron; Vincent L G Postis; Xiaobing Xia; Philip W Fowler; Jean C Ingram; Elisabeth P Carpenter; Mark S P Sansom; Michael J McPherson; Stephen A Baldwin; So Iwata
Journal:  EMBO J       Date:  2010-12-03       Impact factor: 11.598

10.  Identification of two novel genes SLC15A2 and SLCO1B3 associated with maintenance dose variability of warfarin in a Chinese population.

Authors:  Liang-Liang Cai; Wen-Qing Huang; Zhi-Ying Su; Hui-Ming Ye; Lian-Sheng Wang; Yuan Wu; Zhong-Ying Zhang; Wei Zhang; Chi-Meng Tzeng
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.